Oncology Drug Shortage Study Now Recruiting Hematology/Oncology Pharmacists

The ACCP PBRN is proud to announce the launch of the Oncology Drug Shortage Study for ACCP PBRN members who specialize in hematology/oncology. The objective of this study is to determine the impact of cytarabine shortage on the timing, dose, or chemotherapy drug regimen selection for adult patients with acute myeloid leukemia (AML), particularly minority patients with AML, relative to a non-shortage period. Cytarabine is the focus of this research study because shortage of this agent may affect life expectancy, and documented shortage has been widespread.

We invite eligible ACCP PBRN members who practice within the inpatient hematology/oncology specialty area to consider participating in this retrospective data collection research study. The study protocol, central IRB approval letter, data collection tools, and training materials are loaded under step 4 within PBRNConnect: www.accpri.org/signin/index.aspx. This study will use the REDCap Web-based electronic data capture tool. For more information, contact us at [email protected].

All ACCP members are welcome to join the ACCP PBRN at no cost. To be eligible to participate in PBRN projects, members must complete online portfolios within PBRNConnect. If you are already an ACCP member but have not completed your portfolio within PBRNConnect, you may do so at www.accpri.org/signin/index.aspx.

ACCP Research Institute 2012 PRN Report
We want to share with you an update on the activities and success of the Research Institute. Thank you for supporting the ACCP Research Institute.

Join the ACCP PBRN
The ACCP PBRN is a group of clinical pharmacy members from across the United States delivering clinical pharmacy services at a variety of academic, inpatient, outpatient, and other practice settings. Together, this group forms a nationwide network of pharmacists interested in answering research questions. To join the ACCP PBRN, please visit our Web site (www.accpri.org) and complete the online registry form. Once you join the registry, you will need to complete a portfolio with PBRNConnect so that you can participate in any PBRN project (www.accpri.org/pbrnconnect).

The ACCP PBRN continues to grow since its launch in February 2009. We have almost 800 members to date, including members who joined through existing PBRNs and whose data appear below. We encourage each of you to join!

(3/13/2012)

How Do I Join the ACCP PBRN?
The ACCP PBRN has created a one-stop resource for all PBRN-related materials called PBRNConnect. Located at www.accpri.org/pbrnconnect, this resource allows ACCP PBRN members to view, print, and download all research and PBRN-related documents. In addition, the PBRNConnect will serve as a repository for all PBRN-related training. Each ACCP PBRN member will need to upload his or her own portfolio documents within the secure PBRNConnect site to be eligible to participate in ACCP PBRN studies. ACCP PBRN members can access this site using their usual ACCP login. Join the more than 200 PBRN members who already have profiles on PBRNConnect.

Generating Bright Ideas
Do you have a bright idea for the next ACCP PBRN project? Join with the ACCP PBRN to complete your project. The ACCP PBRN is committed to supporting the research efforts of its members. We welcome proposals from ACCP PBRN members and other external investigators looking to collaborate with the ACCP PBRN to facilitate practice-based clinical pharmacy research. To learn more about how to collaborate with the ACCP PBRN, please visit www.accpri.org/pbrn/partner.aspx.

Frontiers Fund: Celebrating Success
The Frontiers Fund helped establish the first national clinical pharmacy practice-based research network (PBRN). We recognize the success of the PBRN is made possible in large part by the contributions of several hundred ACCP members and organizations, as well as many PRNs. However, further success cannot be achieved without additional support. Your tax-deductible donation will develop researchers, build the ACCP PBRN, and generate evidence to further document the value of clinical pharmacy services and advance pharmacy research.
The 2012 Frontiers Fund goals are to receive $100,000 in donations and to increase the percentage of members who donate from 4% to 6%. More information about the Frontiers Fund, including a complete list of donors since 1998, is available at www.accpri.org. Please consider donating to help the Frontiers Fund in 2012 and join the others who have contributed to its success. You can also make online donations at www.accpri.org.

2012 Frontiers Fund Committee: Ron Evens, Susan Fagan (Chair), Stuart Haines, Jimmi Hatton (Chair, Board of Trustees), and Ralph Raasch